Sterling Pharma Solutions expands ADC manufacturing capacity and capabilities
Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions has announced completion of an additional, large─scale GMP manufacturing suite at its dedicated bioconjugation facility in the
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →